Literature DB >> 360299

Effect of prostacyclin (PGI2) on platelet adhesion to rabbit arterial subendothelium.

E A Higgs, S Moncada, J R Vane, J P Caen, H Michel, G Tobelem.   

Abstract

The effect of prostacyclin on platelet aggregation and adhesion was investigated in everted pieces of rabbit abdominal aorta, from which the endothelium had previously been removed. Citrated human blood, to which different, concentrations of prostacyclin (0.1-100 ng/ml) were added, was perfused through the vessels, after which sections were examined and evaluated by light microscopy. Prostacyclin inhibited thrombus formation at concentrations greater than 0.1 ng/ml, whereas 20 ng/ml were required to reduce the amount of adhesion to the subendothelial surface. Thus prostacyclin prevents thrombus formation at much lower concentrations than are needed to inhibit platelet-vessel wall interaction.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 360299     DOI: 10.1016/0090-6980(78)90197-1

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  18 in total

Review 1.  Adventures in vascular biology: a tale of two mediators.

Authors:  S Moncada
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-05-29       Impact factor: 6.237

2.  Role of a nonsteroidal anti-inflammatory agent, ibuprofen, in coronary revascularization after acute myocardial infarction.

Authors:  R Clement; D K Das; R M Engelman; H Otani; D Bandhyopadhyay; S Hoory; M Antar; J A Rousou; R H Breyer; M R Prasad
Journal:  Basic Res Cardiol       Date:  1990 Jan-Feb       Impact factor: 17.165

Review 3.  Nobel lecture, 8th December 1982. Adventures and excursions in bioassay: the stepping stones to prostacyclin.

Authors:  J R Vane
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739

Review 4.  Nobel lecture. Adventures and excursions in bioassay--the stepping stones to prostacyclin.

Authors:  J R Vane
Journal:  Postgrad Med J       Date:  1983-12       Impact factor: 2.401

5.  Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.

Authors:  A H Gershlick; D Spriggins; S W Davies; Y D Syndercombe Court; J Timmins; A D Timmis; M T Rothman; C Layton; R Balcon
Journal:  Br Heart J       Date:  1994-01

Review 6.  Gliclazide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus.

Authors:  B Holmes; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

7.  Recovery of endothelial cell prostacyclin production after inhibition by low doses of aspirin.

Authors:  E A Jaffe; B B Weksler
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

8.  Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro.

Authors:  M Hirafuji; H Shinoda
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

9.  Concentrations of prostaglandin endoperoxide synthase and prostaglandin I2 synthase in the endothelium and smooth muscle of bovine aorta.

Authors:  D L DeWitt; J S Day; W K Sonnenburg; W L Smith
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

Review 10.  Prostaglandin I2 (prostacyclin).

Authors:  J G Kelton; M A Blajchman
Journal:  Can Med Assoc J       Date:  1980-01-26       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.